<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-09-24</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308420/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308420-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Alterations within the tryptophan-kynurenine metabolic pathway have been linked to the etiology of colorectal cancer (CRC), but the relevance of this pathway for prognostic outcomes in CRC patients needs further elucidation. Therefore, we investigated associations between circulating concentrations of tryptophan-kynurenine pathway metabolites and all-cause mortality among CRC patients. This study utilizes data from 2102 stage I-III CRC patients participating in six prospective cohorts &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308505/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">The past, present, and future of the brain imaging data structure (BIDS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308505-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Brain Imaging Data Structure (BIDS) is a community-driven standard for the organization of data and metadata from a growing range of neuroscience modalities. This paper is meant as a history of how the standard has developed and grown over time. We outline the principles behind the project, the mechanisms by which it has been extended, and some of the challenges being addressed as it evolves. We also discuss the lessons learned through the project, with the aim of enabling researchers &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308634/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308634-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Artificial intelligence-based auto-segmentation programs showed high-quality accuracy and provided standardization and efficient support for guideline-based target volume contouring as a precondition for fully automated workflows in radiotherapy treatment &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309033/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Searches for new physics below twice the electron mass with GERDA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309033-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A search for full energy depositions from bosonic keV-scale dark matter candidates of masses between 65 and 1021 keV has been performed with data collected during Phase II of the GERmanium Detector Array (Gerda) experiment. Our analysis includes direct dark matter absorption as well as dark Compton scattering. With a total exposure of 105.5 kg years, no evidence for a signal above the background has been observed. The resulting exclusion limits deduced with either Bayesian or &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309618/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309618-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: ALKTERNATE revealed feasibility with a novel alternating ALK inhibitor strategy in ALK-positive NSCLC. Results support progressing inquiry into this approach and propose a flexible design with drug(s) selected and alternating time frames, informed by real-time plasma profiling. Moving this concept to treatment naive may also optimize &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309700/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Individual-level determinants of breast and cervical cancer screening and early testing in two regionally representative urban Indian populations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309700-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings may have important implications for interventions at community-level (e.g., reducing &lsquo;fear-of-judgement&rsquo;, increasing awareness to screening programs and early symptoms) and health-system level (e.g., opportunistic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310222/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Optimising inter-patient image registration for image-based data mining in breast radiotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310222-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: B-spline algorithm using NMI and registered supine and prone cohorts independently provides the most optimal spatial normalisation strategy for breast &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310358/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Surgical Outcomes and Sociodemographic Disparities Across All Races: An ACS-NSQIP and NHIS Multi-Institutional Analysis of Over 7.5 Million Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310358-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study underscores racial disparities in surgical outcomes. Focused investigations into these complications could reveal underlying causes, informing healthcare policies to enhance surgical care &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310744/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Analytical performance evaluation of a new integrated clinical chemistry and immunoassay analyzer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310744-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This is the first reported evaluation of the Atellica CI Analyzer in a clinical laboratory setting. The strong analytical performance of the Atellica CI Analyzer demonstrates that this instrument is suitable for routine clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310847/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310847-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The NanoString GeoMx® DSP platform delivers robust data to interrogate tumor heterogeneity, but tissue storage time should be considered when interpreting the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311030/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Time-resolved photoelectron diffraction imaging of methanol photodissociation involving molecular hydrogen ejection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311030-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Imaging ultrafast atomic and molecular hydrogen motion with femtosecond time resolution is a challenge for ultrafast spectroscopy due to the low mass and small scattering cross section of the moving neutral hydrogen atoms and molecules. Here, we propose time- and momentum-resolved photoelectron diffraction (TMR-PED) as a way to overcome limitations of existing methodologies and illustrate its performance using a prototype molecular dissociation process involving the sequential ejection of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311051/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Is tumour sequencing effective for the identification of germline &lt;em&gt;BRCA1/2&lt;/em&gt; pathogenic variant carriers?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311051-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In our tumour-to-germline testing approach, we observed the BRCA1/2 pathogenic variant frequency reported in other large unselected ovarian cancer cohorts, thus confirming its effectiveness in identifying putative germline carriers irrespective of eligibility for germline testing. As the range of tumours subjected to genetic testing broadens, this approach is expected to also be effective in other tumour settings for enhancing the identification of carriers, reducing the burden &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311115/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">Accessible Weight Scales and Exam Tables - New Federal Regulations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311115-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311116/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">The Role of Physicians on Ethics Committees after &lt;em&gt;Dobbs&lt;/em&gt;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311116-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311134/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">&lt;em&gt;Dobbs&lt;/em&gt; Revisited - Addressing Effects on Resident Training in Obstetrics and Gynecology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311134-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311216/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Indications for testosterone therapy in men</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311216-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Testosterone replacement therapy for men with organic hypogonadism due to medical disease of the hypothalamic-pituitary-testicular (HPT) axis is uncontroversial. In these men, testosterone replacement replaces the deficient hormone and relieves the signs and symptoms of androgen deficiency. In contrast, the role of testosterone treatment in middle-aged or older men who have clinical features consistent with androgen deficiency accompanied by reductions in serum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311249/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">Button-Battery Ingestion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311249-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311354/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Risk Factors and Preventive Measures for Lung Cancer in the European Union</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311354-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Lung cancer is a significant global health challenge. The study identified potential strategies for reducing the mortality rate from lung cancer. These strategies include an increase in the number of physicians, enhanced accessibility to cutting-edge antineoplastic medications, and state-funded coverage of the associated costs. It would be beneficial for politicians to consider implementing LDCT screening for the early detection of the disease. The implementation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311364/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311364-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Driven by technological innovations, newborn screening (NBS) panels have been expanded and the development of genomic NBS pilot programs is rapidly progressing. Decisions on disease selection for NBS are still based on the Wilson and Jungner (WJ) criteria published in 1968. Despite this uniform reference, interpretation of the WJ criteria and actual disease selection for NBS programs are highly variable. A systematic literature search [PubMED search &ldquo;Wilson&rdquo; AND &ldquo;Jungner&rdquo;; last search &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311774/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Telerehabilitation Compared to Center-based Pulmonary Rehabilitation for People with Chronic Respiratory Disease: Economic Analysis of a Randomized, Controlled Clinical Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311774-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    RATIONALE: New pulmonary rehabilitation models can improve access to this effective but underutilised treatment for people with chronic respiratory disease, however cost effectiveness has not been &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311864/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Validation of the Late-Life Function and Disability Instrument in People Living with COPD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311864-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The LLFDI, a valid patient-reported outcome to investigate disability and function, has proven good construct validity in people with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311911/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311911-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N[w]-nitro-l-arginine methyl ester (L-NAME) recapitulate features of HFpEF in mice. To identify disease-specific traits during adverse remodeling, we profiled interstitial cells in early murine HFpEF using single-cell RNAseq (scRNAseq). Diastolic dysfunction and perivascular fibrosis were accompanied by an &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312093/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Correction: Prevention at home in older persons with (pre-)frailty: analysis of participants&#39; recruitment and characteristics of the randomized controlled PromeTheus trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312093-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312195/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240923200250&amp;v=2.18.0.post9&#43;e462414">Selective Enhancer Gain of Function Deregulates MYC Expression in Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312195-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240923200250-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MYC deregulation occurs in the majority of multiple myeloma (MM) cases and is associated with progression and worse prognosis. Enhanced MYC expression occurs in about 70% of MM patients, but it is known to be driven by translocation or amplification events in only ~40% of myelomas. Here, we used CRISPR interference (CRISPRi) to uncover an epigenetic mechanism of MYC regulation whereby increased accessibility of a plasma cell-type specific enhancer leads to increased MYC expression. This &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312541/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312541-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Findings from our large real-life registry confirm the data from RCTs and extend our knowledge on the effectiveness and safety of DOACs to subjects that were underrepresented in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oyh4uaRSV">很多人在私信里问如何保证每天口服一次必妥维的依从性。其实不光是HIV抗病毒药，服用其他控制慢性疾病药物如降压药、降糖药和调血脂药也需要保证良好依从性。我...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oyh4uarsv/">
    
    
    
    
    
      
    
    很多人在私信里问如何保证每天口服一次必妥维的依从性。其实不光是HIV抗病毒药，服用其他控制慢性疾病药物如降压药、降糖药和调血脂药也需要保证良好依从性。我最近工作中就需要分析患者的依从性数据，其实在临床上，医生监测患者依从性也是让患者数药瓶中的药物数量，以此来监测患者依从性。这里除了每天服药的时候上闹钟以外，还有一个很好的方法就是实时统计，现在有很多服药App可以帮助患者监测依从性，这些App有每天提醒功能，也有药物数量监测功能。除此以外，一个很好的办法是可以建立一个excel表格，在每一段时间，更新药瓶里的药物数量，以此来监测依从性。如果今天忘记自己是否服药，可以看表格中药片数量和自己实际药瓶数量中是否有差 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OynLRkMnT">我不知道你们为什么老嚷嚷什么成建制美国换皮什么的……想象不出靠美军的招募体系和军事纪律怎么支撑你们这样的想法。//@村边两条河:以色列嚷嚷了那么长时间的北...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oynlrkmnt/">
    
    
    
    
    
      
    
    我不知道你们为什么老嚷嚷什么成建制美国换皮什么的……想象不出靠美军的招募体系和军事纪律怎么支撑你们这样的想法。//<!-- raw HTML omitted -->@村边两条河<!-- raw HTML omitted -->:以色列嚷嚷了那么长时间的北伐，一直拖到现在才行动，背后肯定有阴谋的，一方面是针对黎巴嫩的信息搜集和暗杀行动。另一手准备极有可能是跟美国的换皮部队在进行联合作战训练，原来一个师的人员与火力先，现在有可能变成一个集团军<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻以色列国防军总参谋长赫尔齐·哈勒维中将表示，“以色列军方正在瓦解真主党 20 年来建立起来的能力。”<!-- raw HTML omitted -->🔻……不是，你连南黎三八线级别的地下工事群边都没挨着，搁这儿吹牛批可还行？骗人骗己，能骗得了我们东亚怪物房么？<!-- raw HTML omitted -->🔻via &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyo5wf6pG">🔻现在没有睡的原因是一边刷黎以对轰，一边刷某漫画工作室员工前员工对轰[哆啦A梦吃惊]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyo5wf6pg/">
    
    
    
    
    
      
    
    🔻现在没有睡的原因是一边刷黎以对轰，一边刷某漫画工作室员工前员工对轰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyo9Cmr5H">🔻#极乐鸟工作室#这瓜吃的我睡意全无[哆啦A梦吃惊]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyo9cmr5h/">
    
    
    
    
    
      
    
    🔻<!-- raw HTML omitted --><!-- raw HTML omitted -->#极乐鸟工作室#<!-- raw HTML omitted --><!-- raw HTML omitted -->这瓜吃的我睡意全无<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyoa6dbCn">黎巴嫩al-m、卡塔尔aja、路透社、以色列时报和新消息报这几家媒体官网都开了新闻live模式。//@Astanian:在 什么网站刷黎巴嫩以色列对轰的啊？ - 转发 @包容万物...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoa6dbcn/">
    
    
    
    
    
      
    
    黎巴嫩al-m、卡塔尔aja、路透社、以色列时报和新消息报这几家媒体官网都开了新闻live模式。//<!-- raw HTML omitted -->@Astanian<!-- raw HTML omitted -->:在 什么网站刷黎巴嫩以色列对轰的啊？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻现在没有睡的原因是一边刷黎以对轰，一边刷某漫画工作室员工前员工对轰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyoe27Q8G">🔻目前就看到@极乐鸟-爱画画 和另一位出来回应了一大堆。🔻另外一边参与声讨的前员工也有不少。🔻怎么讲……这瓜吃的心情有点复杂[哆啦A梦吃惊]。#极乐鸟...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoe27q8g/">
    
    
    
    
    
      
    
    🔻目前就看到<!-- raw HTML omitted -->@极乐鸟-爱画画<!-- raw HTML omitted --> 和另一位出来回应了一大堆。<!-- raw HTML omitted -->🔻另外一边参与声讨的前员工也有不少。<!-- raw HTML omitted -->🔻怎么讲……这瓜吃的心情有点复杂<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->。<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5%B7%A5%E4%BD%9C%E5%AE%A4%23&amp;amp;extparam=%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5%B7%A5%E4%BD%9C%E5%AE%A4%23&amp;amp;extparam=%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyokehgc5">🔻为了方便大家半夜吃瓜，我把几个当事人最重要的几条微博整合在这里：🔻@真-柳堡 的关键几篇在图1-图4🔻@A-soul韩超 的回应在图5-7🔻@极乐鸟-爱画画 的...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyokehgc5/">
    
    
    
    
    
      
    
    🔻为了方便大家半夜吃瓜，我把几个当事人最重要的几条微博整合在这里：<!-- raw HTML omitted -->🔻<!-- raw HTML omitted -->@真-柳堡<!-- raw HTML omitted --> 的关键几篇在图1-图4<!-- raw HTML omitted -->🔻<!-- raw HTML omitted -->@A-soul韩超<!-- raw HTML omitted --> 的回应在图5-7<!-- raw HTML omitted -->🔻<!-- raw HTML omitted -->@极乐鸟-爱画画<!-- raw HTML omitted --> 的回应在图8<!-- raw HTML omitted -->🔻<!-- raw HTML omitted -->@恶臭生鲜<!-- raw HTML omitted --> 的回应在图9<!-- raw HTML omitted -->🔻还有一些前员工的发言在相关微博评论区<!-- raw HTML omitted -->🔻作为路人，我看完之后仍不知谁对谁错，作为A-soul诸多作品和中国国产漫画从画王时代就一如既往支持、关注的读者，我看完之后心情复杂。<!-- raw HTML omitted -->🔻这个复杂不仅仅是因为这个瓜的，还有关于这个行业燃烧了不知道多少人的热爱和青春的。<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyomUBIAl">🔻我不知道这个比喻对不对。就有一点点像看五黑框的感觉。#极乐鸟工作室#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyomubial/">
    
    
    
    
    
      
    
    🔻我不知道这个比喻对不对。就有一点点像看五黑框的感觉。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#极乐鸟工作室#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyop30OPa">问的好，这个行业的无数场撕逼，大都源于此//@桃子屁屁小馒头:这个行业燃烧了不知道多少人的热爱和青春，既得利益者到底是谁呢 - 转发 @包容万物恒河水:&amp;ensp;�...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyop30opa/">
    
    
    
    
    
      
    
    问的好，这个行业的无数场撕逼，大都源于此//<!-- raw HTML omitted -->@桃子屁屁小馒头<!-- raw HTML omitted -->:这个行业燃烧了不知道多少人的热爱和青春，既得利益者到底是谁呢<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻为了方便大家半夜吃瓜，我把几个当事人最重要的几条微博整合在这里：<!-- raw HTML omitted -->🔻<!-- raw HTML omitted -->@真-柳堡<!-- raw HTML omitted --> 的关键几篇在图1-图4<!-- raw HTML omitted -->🔻<!-- raw HTML omitted -->@A-soul韩超<!-- raw HTML omitted --> 的回应在图5-7<!-- raw HTML omitted -->🔻&lt;a href=&ldquo;<a href="https://weibo.com/n/%E6%9E%81%E4%B9%90%E9%B8%9F-%E7%88%B1%E7%94%BB%25E">https://weibo.com/n/%E6%9E%81%E4%B9%90%E9%B8%9F-%E7%88%B1%E7%94%BB%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyosKAop0">🔻曾经，wow的首杀团好像也出过类似的事情……🔻我对那个小镇上的工作室也记忆犹新。#极乐鸟工作室#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoskaop0/">
    
    
    
    
    
      
    
    🔻曾经，wow的首杀团好像也出过类似的事情……<!-- raw HTML omitted -->🔻我对那个小镇上的工作室也记忆犹新。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#极乐鸟工作室#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyph9p4Ns">🔻黎巴嫩卫生部：以军当天对黎巴嫩多地发动空袭造成的死 亡人数升至492人，另有1645人受伤。🔻图为黎巴嫩媒体公布的部分遇 难 者。#以军空袭黎巴嫩多地致275...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyph9p4ns/">
    
    
    
    
    
      
    
    🔻黎巴嫩卫生部：以军当天对黎巴嫩多地发动空袭造成的死 亡人数升至492人，另有1645人受伤。<!-- raw HTML omitted -->🔻图为黎巴嫩媒体公布的部分遇 难 者。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#以军空袭黎巴嫩多地致275死1024伤#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbgy1htyd2jzz2tj20zu12vwmc.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbgy1htyd2jzz2tj20zu12vwmc.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OykeUzfHd">過度努力有害健康的[泪] - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.09.22 20:29「欸嘿嘿」呜哇哇～每天都在努力虽然有时候有点过度努力了但是...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oykeuzfhd/">
    
    
    
    
    
      
    
    過度努力有害健康的<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/201">https://n.sinaimg.cn/photo/5213b46e/201</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OylW7xnJb">久保史绪里 via.乃木恋 [图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oylw7xnjb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.乃木恋 <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1htxyd4qjjbj30hs0nqair.jp">https://tvax2.sinaimg.cn/large/006z6nxLgy1htxyd4qjjbj30hs0nqair.jp</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oymgag7vp">久保史绪里#久保史绪里手机博# 2024.09.23 16:21「好嘞」早上好从早上就开始努力啦最近感觉总在听チートデイ。似乎是因为秋天的来临感到不舍。。虽然这么说，似...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oymgag7vp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%B</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

